Facebook
Twitter
LinkedIn
Forward
Lauren M.B. Burke, MD, and Katrina A. McGinty, MD, provide an overview of different imaging modalities for imaging the abdomen, as well as some of their common indications and patient-specific limitations. They will also discuss an overview of commonly used imaging modalities with an emphasis on understanding different modalities' strengths and limitations. The goal is to provide instruction on deciding when different imaging modalities and tests are appropriate for different pathologies.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will go into more detail for treatment options and considerations for treating localized prostate cancer and the management of side effects.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will provide a general overview of Prostate Cancer. The audience will learn about basic pathophysiology and epidemiology as it relates to both local and advanced disease. This course will then provide insight into the pros & cons of prostate cancer screening as well as the accepted diagnostic procedures & scoring.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will discuss the different treatment options for advanced prostate cancer as well as considerations for management side effects and maximizing a survivor’s quality of life.
|
In working to address Native American cancer health disparities, it is imperative to build partnerships with tribal communities to increase their trust in the potential benefits of cancer research efforts. The Partnership for Native American Cancer Prevention was established in 2002 and the Partnership’s approach is to expand capacity for culturally-sensitive and community-relevant research on cancer and to continue to develop respectful collaborations that empower sovereign Native American communities to define, implement, and achieve their goals for cancer health equity.
|
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.
|
Joe Polich, MSW, LCSWA, JD will provide a foundational knowledge to providers who come in contact with patients with cancer who are also experiencing IPV. Beginning with a quick introduction to some basic concepts of the dynamics of IPV in general, we will discuss the intersection of the provision of care to a patient with cancer and the dynamics involved in IPV.
|
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
|
Zev Nakamura, MD will present on key topics related to cognitive issues experienced by patients with cancer.
|
Lauren Lux, MSW and Melissa Matson, MSN, RN, AGPCNP-BC and Catharine Swift, MSW, LCSW highlight tools and strategies that healthcare providers can deploy to meet the medical and psychosocial needs of the AYAs in their care.
|